Insights from 2023 ASCO® Annual Meeting


 

ASCO® 2023 Insights: "Updated Results for Cohort H of EV-103 Trial - Neoadjuvant Treatment With Enfortumab Vedotin Monotherapy in Cisplatin-Ineligible Patients With MIBC"

111 views
June 12, 2023
Comments 0
Login to view comments. Click here to Login